Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
13h
New Biomarker Discovered For Cognitive Symptoms Of Schizophrenia, Could Serve As Drug Target: Study
A study has found a new biomarker of schizophrenia, which could also serve as a drug target for treating cognitive symptoms ...
Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to ...
Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...
Schizophrenia is a complex mental health condition characterized by a disruption in a person’s thoughts, perceptions, emotions, and behavior. It can be a debilitating condition, but with proper ...
Researchers found a grin2a mutation disrupts a brain circuit that updates beliefs using new information. In mice, restoring ...
Discover innovative schizophrenia treatment options targeting cognitive symptoms for improved patient independence.
A University of Kentucky researcher is leading a team in what the university calls a groundbreaking study. According to UK, the study identifies biological markers for schizophrenia, which could ...
Acadia Pharmaceuticals said Monday that its approved medicine called Nuplazid failed to improve the social and emotional symptoms of schizophrenia in a late-stage clinical trial. The negative outcome ...
The symptoms of schizophrenia vary greatly from person to person, and a newly reported international multicenter study, headed by a research team at the University of Zurich, has found that these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results